BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36758318)

  • 1. The potential role of m6A modifications on immune cells and immunotherapy.
    Gan L; Zhao Y; Fu Y; Chen Q
    Biomed Pharmacother; 2023 Apr; 160():114343. PubMed ID: 36758318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
    Pan J; Huang T; Deng Z; Zou C
    Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.
    Kumari S; Kumar S; Muthuswamy S
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1621-1633. PubMed ID: 35796777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
    Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
    Front Immunol; 2022; 13():819080. PubMed ID: 35359993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism.
    Yue SW; Liu HL; Su HF; Luo C; Liang HF; Zhang BX; Zhang W
    Mol Cancer; 2023 Aug; 22(1):137. PubMed ID: 37582735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
    Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
    Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
    Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
    Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
    Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
    Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis.
    Zhao W; Li J; Ma Q; Cai J; Li A; Wu W; Lv Y; Cai M
    J Cell Physiol; 2022 Jul; 237(7):2729-2739. PubMed ID: 35342948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.
    Chen F; Xie X; Chao M; Cao H; Wang L
    Front Immunol; 2022; 13():917153. PubMed ID: 35711459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma.
    Wang G; Zeng D; Sweren E; Miao Y; Chen R; Chen J; Wang J; Liao W; Hu Z; Kang S; Garza LA
    J Invest Dermatol; 2023 Aug; 143(8):1579-1590.e5. PubMed ID: 36842525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of m6A modification in immune microenvironment of digestive system tumors.
    Li C; Zhu M; Wang J; Wu H; Liu Y; Huang D
    Biomed Pharmacother; 2023 Aug; 164():114953. PubMed ID: 37269812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
    Zhang Y; Zhan L; Li J; Jiang X; Yin L
    Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new perspective on hematological malignancies: m6A modification in immune microenvironment.
    Yang S; Xu L; Zhuang H; Li F; Lu Y
    Front Immunol; 2024; 15():1374390. PubMed ID: 38868768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
    Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
    Front Immunol; 2021; 12():789914. PubMed ID: 34887874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.